デフォルト表紙
市場調査レポート
商品コード
1610266

空気圧圧迫療法市場:コンポーネント別、用途別-2025-2030年の世界予測

Pneumatic Compression Therapy Market by Components (Controller & Pump, Wearables), Application (Deep Vein Thrombosis Treatment, Lymphedema, Varicose Vein Treatment) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 196 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
空気圧圧迫療法市場:コンポーネント別、用途別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

空気圧圧迫療法市場は、2023年に42億8,000万米ドルと評価され、2024年には45億9,000万米ドルに達すると予測され、CAGR 6.23%で成長し、2030年には65億4,000万米ドルになると予測されています。

空気圧圧迫療法(PCT)には、循環を改善し、腫れを抑え、静脈障害を緩和するために膨張式器具を使用することが含まれます。この治療は、特にリンパ浮腫、深部静脈血栓症、静脈うっ滞性潰瘍などのリンパ・血管疾患の管理に不可欠です。手術後の回復やスポーツ傷害のリハビリテーションなど、さまざまな使用事例があり、非侵襲的な代替治療を提供するため、その適用範囲は病院、診療所、家庭環境まで広がっています。世界の空気圧圧迫療法市場は、静脈疾患に対する意識の高まり、リンパ浮腫の発生率の上昇、高齢者人口の増加などを背景に成長を遂げています。健康意識の高まりと技術の進歩により、製品革新、特に個別ケアのためのユーザーフレンドリーな機器や、患者モニタリングと転帰追跡のための統合スマート技術にビジネスチャンスが溢れています。さらに、ヘルスケア機関との提携やターゲットを絞ったマーケティング戦略により、需要の拡大を活用できる可能性があります。

主な市場の統計
基準年[2023] 42億8,000万米ドル
推定年[2024] 45億9,000万米ドル
予測年[2030] 65億4,000万米ドル
CAGR(%) 6.23%

しかし、圧迫装置の高額なコストやメンテナンス、未発達地域における認知度の低さ、厳しい規制環境など、特定の課題や制約が市場の成長を阻害する可能性があります。費用の補助や広範な教育キャンペーンを通じてこれらの障壁に対処することで、市場への浸透を高めることができます。技術革新のための最良の分野には、予測分析と治療のカスタマイズのための人工知能と機械学習の統合、携帯可能で環境に優しい機器の開発、遠隔患者サポートのための遠隔医療機能の実装が含まれます。

成長を持続させるためには、市場参加者は費用対効果の高い効率的なソリューションの調査を取り入れ、データ主導の洞察力を活用して患者中心の戦略を策定し、規制機関と連携して承認プロセスを合理化すべきです。市場は競争が激しく、急速な進歩や、新たなヘルスケア政策や消費者ニーズへの継続的な適応の必要性を特徴としています。企業は継続的な研究開発を優先させることで、市場での地位を強化し、患者の治療成果を向上させるという空気圧圧迫療法の可能性を最大限に引き出すことができます。

市場力学:急速に進化する空気圧圧迫療法市場の主要市場インサイトを公開

空気圧圧迫療法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 深部静脈血栓症、下腿潰瘍、リンパ浮腫、血栓、静脈瘤の有病率の上昇
    • スポーツ外傷や事故の増加
    • 治療オプションに関する患者の意識の高まり
  • 市場抑制要因
    • 空気圧圧迫療法製品に関連する副作用
  • 市場機会
    • 空気圧圧迫療法製品の技術的進歩
    • 整形外科手術数の増加
  • 市場の課題
    • 空気圧迫の代替品

ポーターのファイブフォース:空気圧圧迫療法市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:空気圧圧迫療法市場における外部からの影響の把握

外部マクロ環境要因は、空気圧圧迫療法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析空気圧圧迫療法市場における競合情勢の把握

空気圧圧迫療法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス空気圧圧迫療法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、空気圧圧迫療法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨空気圧圧迫療法市場における成功への道筋を描く

空気圧圧迫療法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 深部静脈血栓症、下肢潰瘍、リンパ浮腫、血栓、静脈瘤の罹患率が上昇
      • スポーツによる傷害や事故の増加
      • 治療の選択肢に関する患者の意識の高まり
    • 抑制要因
      • 空気圧圧迫療法製品に関連する副作用
    • 機会
      • 空気圧圧迫療法製品における技術的進歩
      • 整形外科手術の増加
    • 課題
      • 空気圧縮の代替手段
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 空気圧圧迫療法市場:コンポーネント別

  • コントローラーとポンプ
  • ウェアラブル

第7章 空気圧圧迫療法市場:用途別

  • 深部静脈血栓症の治療
  • リンパ浮腫
  • 静脈瘤の治療

第8章 南北アメリカの空気圧圧迫療法市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の空気圧圧迫療法市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの空気圧圧迫療法市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Arjo Inc. by Getinge
  • B. Braun
  • Bosl Medizintechnik GmbH
  • Cardinal Health, Inc
  • DJO Global, Inc.
  • ElastiMed
  • Eureduc
  • Lohmann & Rauscher
  • Medline Industries, LP.
  • Mego Afek ltd.
  • Paul Hartmann
  • Sigvaris Group
  • Smith & Nephew PLC
  • Talley Group Ltd. by Direct Healthcare Group
  • Venosan by Salzmann AG
図表

LIST OF FIGURES

  • FIGURE 1. PNEUMATIC COMPRESSION THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PNEUMATIC COMPRESSION THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PNEUMATIC COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PNEUMATIC COMPRESSION THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PNEUMATIC COMPRESSION THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PNEUMATIC COMPRESSION THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY CONTROLLER & PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY WEARABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY VARICOSE VEIN TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PNEUMATIC COMPRESSION THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PNEUMATIC COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. PNEUMATIC COMPRESSION THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-02026C4C8E48

The Pneumatic Compression Therapy Market was valued at USD 4.28 billion in 2023, expected to reach USD 4.59 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 6.54 billion by 2030.

Pneumatic Compression Therapy (PCT) involves using inflatable devices to improve circulation, reduce swelling, and alleviate venous disorders. This treatment is essential in managing lymphatic and vascular conditions, especially lymphedema, deep vein thrombosis, and venous stasis ulcers. The scope of its application extends to hospitals, clinics, and home settings, as it provides a non-invasive treatment alternative with various use cases including post-operative recovery and sports injury rehabilitation. The global pneumatic compression therapy market is witnessing growth driven by increasing awareness of venous disorders, the rising incidence of lymphedema, and a growing geriatric population. With heightened health consciousness and technological advancement, opportunities abound in product innovation, particularly in user-friendly devices for personalized care and integrated smart technology for patient monitoring and outcome tracking. Additionally, partnerships with healthcare institutions and targeted marketing strategies could capitalize on growing demand.

KEY MARKET STATISTICS
Base Year [2023] USD 4.28 billion
Estimated Year [2024] USD 4.59 billion
Forecast Year [2030] USD 6.54 billion
CAGR (%) 6.23%

However, certain challenges and limitations might impede market growth, including the high cost and maintenance of compression devices, lack of awareness in underdeveloped regions, and stringent regulatory environments. Addressing these barriers through subsidizing costs and extensive education campaigns can enhance market penetration. Best areas for innovation involve the integration of artificial intelligence and machine learning for predictive analytics and treatment customization, development of portable and eco-friendly devices, and implementation of tele-health capabilities for remote patient support.

To sustain growth, market players should embrace research into cost-effective and efficient solutions, harnessing data-driven insights to formulate patient-centric strategies and engage with regulatory bodies to streamline approval processes. The market is highly competitive, characterized by rapid advancements and the need for continuous adaptation to new healthcare policies and consumer needs. By prioritizing ongoing research and development, businesses can strengthen their market position and exploit the full potential of pneumatic compression therapy in enhancing patient care outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pneumatic Compression Therapy Market

The Pneumatic Compression Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of deep vein thrombosis, leg ulcers, lymphedema, blood clots, and varicose veins
    • Increase in the number of sports injuries and accidents
    • Growing awareness among patients regarding treatment options
  • Market Restraints
    • Adverse effects associated with pneumatic compression therapy products
  • Market Opportunities
    • Technological advancements in pneumatic compression therapy products
    • Rising number of orthopedic procedures
  • Market Challenges
    • Alternatives to Pneumatic Compression

Porter's Five Forces: A Strategic Tool for Navigating the Pneumatic Compression Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pneumatic Compression Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pneumatic Compression Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pneumatic Compression Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pneumatic Compression Therapy Market

A detailed market share analysis in the Pneumatic Compression Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pneumatic Compression Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pneumatic Compression Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pneumatic Compression Therapy Market

A strategic analysis of the Pneumatic Compression Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pneumatic Compression Therapy Market, highlighting leading vendors and their innovative profiles. These include Arjo Inc. by Getinge, B. Braun, Bosl Medizintechnik GmbH, Cardinal Health, Inc, DJO Global, Inc., ElastiMed, Eureduc, Lohmann & Rauscher, Medline Industries, LP., Mego Afek ltd., Paul Hartmann, Sigvaris Group, Smith & Nephew PLC, Talley Group Ltd. by Direct Healthcare Group, and Venosan by Salzmann AG.

Market Segmentation & Coverage

This research report categorizes the Pneumatic Compression Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Components, market is studied across Controller & Pump and Wearables.
  • Based on Application, market is studied across Deep Vein Thrombosis Treatment, Lymphedema, and Varicose Vein Treatment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of deep vein thrombosis, leg ulcers, lymphedema, blood clots, and varicose veins
      • 5.1.1.2. Increase in the number of sports injuries and accidents
      • 5.1.1.3. Growing awareness among patients regarding treatment options
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with pneumatic compression therapy products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in pneumatic compression therapy products
      • 5.1.3.2. Rising number of orthopedic procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Alternatives to Pneumatic Compression
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pneumatic Compression Therapy Market, by Components

  • 6.1. Introduction
  • 6.2. Controller & Pump
  • 6.3. Wearables

7. Pneumatic Compression Therapy Market, by Application

  • 7.1. Introduction
  • 7.2. Deep Vein Thrombosis Treatment
  • 7.3. Lymphedema
  • 7.4. Varicose Vein Treatment

8. Americas Pneumatic Compression Therapy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pneumatic Compression Therapy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pneumatic Compression Therapy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arjo Inc. by Getinge
  • 2. B. Braun
  • 3. Bosl Medizintechnik GmbH
  • 4. Cardinal Health, Inc
  • 5. DJO Global, Inc.
  • 6. ElastiMed
  • 7. Eureduc
  • 8. Lohmann & Rauscher
  • 9. Medline Industries, LP.
  • 10. Mego Afek ltd.
  • 11. Paul Hartmann
  • 12. Sigvaris Group
  • 13. Smith & Nephew PLC
  • 14. Talley Group Ltd. by Direct Healthcare Group
  • 15. Venosan by Salzmann AG